JP2017502064A5 - - Google Patents

Download PDF

Info

Publication number
JP2017502064A5
JP2017502064A5 JP2016545857A JP2016545857A JP2017502064A5 JP 2017502064 A5 JP2017502064 A5 JP 2017502064A5 JP 2016545857 A JP2016545857 A JP 2016545857A JP 2016545857 A JP2016545857 A JP 2016545857A JP 2017502064 A5 JP2017502064 A5 JP 2017502064A5
Authority
JP
Japan
Prior art keywords
aqueous solution
concentration
providing
pirfenidone
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016545857A
Other languages
English (en)
Other versions
JP7066321B2 (ja
JP2017502064A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/010890 external-priority patent/WO2015106150A1/en
Publication of JP2017502064A publication Critical patent/JP2017502064A/ja
Publication of JP2017502064A5 publication Critical patent/JP2017502064A5/ja
Application granted granted Critical
Publication of JP7066321B2 publication Critical patent/JP7066321B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (6)

  1. 噴霧化吸入投与のための水溶液であって:
    水;
    5.0mg/mL乃至約18.0mg/mLの濃度のピルフェニドン;
    1.0mg/mL乃至20.0mg/mLの濃度のクエン酸ナトリウム;
    1mM乃至10mMの濃度のクエン酸;
    100mM乃至200mMの濃度の塩化ナトリウム;及び
    0.5mM乃至0.9mMの濃度のサッカリンナトリウム
    を含み;
    サッカリンナトリウムとピルフェニドンのモル比が1対53.9〜1対215.9であり、
    水溶液の重量オスモル濃度が約250mOsmol/kg乃至約500mOsmol/kgであり、及び
    水溶液のpHは約5.0乃至約6.0である
    ことを特徴とする水溶液。
  2. 塩化ナトリウム濃度は約150mMである、ことを特徴とする請求項1に記載の水溶液。
  3. クエン酸ナトリウム濃度は約3.5mMであり、クエン酸濃度は約1.5mMである、ことを特徴とする請求項2に記載の水溶液。
  4. pHは約5.5である、ことを特徴とする請求項2に記載の水溶液。
  5. 約0.5mL乃至約6mLの水溶液を含む振動メッシュ噴霧器に使用するために適用される、請求項1乃至4の何れか1つに記載の水溶液の単位投与量。
  6. 液体噴霧器は、
    (i)吸入された用量の投与後、哺乳動物に投与されたピルフェニドンの少なくとも7%の肺沈着を達成し;
    (ii)約1.0μm乃至約2.5μmの水溶液の放出された液滴直径分布の幾何学的な標準偏差(GSD)を提供し;
    (iii)
    a)空気動力学的中央粒子径(MMAD)が約0.5μm乃至約5μm;及び/又は
    b)容量平均直径(VMD)が約0.5μm乃至約5μm
    である高効率の液体と共に放出された水溶液の液滴を提供し;
    (iv)少なくとも約30%の液体噴霧器から放出された液滴の微粒子画分(FPF=%≦5μm)を提供し;
    (v)少なくとも0.1mL/minの出力速度を提供し;及び/又は
    (vi)水溶液の少なくとも約25%を哺乳動物に与える
    ことを特徴とする請求項5に記載の単位投与量。
JP2016545857A 2014-01-10 2015-01-09 エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 Active JP7066321B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201461925791P 2014-01-10 2014-01-10
US61/925,791 2014-01-10
US201461951686P 2014-03-12 2014-03-12
US61/951,686 2014-03-12
US201461977529P 2014-04-09 2014-04-09
US61/977,529 2014-04-09
US201462000473P 2014-05-19 2014-05-19
US62/000,473 2014-05-19
PCT/US2015/010890 WO2015106150A1 (en) 2014-01-10 2015-01-09 Aerosol pirfenidone and pyridone analog compounds and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019224874A Division JP2020090494A (ja) 2014-01-10 2019-12-12 エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用

Publications (3)

Publication Number Publication Date
JP2017502064A JP2017502064A (ja) 2017-01-19
JP2017502064A5 true JP2017502064A5 (ja) 2018-03-01
JP7066321B2 JP7066321B2 (ja) 2022-05-13

Family

ID=53520401

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016545857A Active JP7066321B2 (ja) 2014-01-10 2015-01-09 エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
JP2019224874A Pending JP2020090494A (ja) 2014-01-10 2019-12-12 エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
JP2021165604A Pending JP2022017283A (ja) 2014-01-10 2021-10-07 エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
JP2023196892A Pending JP2024028720A (ja) 2014-01-10 2023-11-20 エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019224874A Pending JP2020090494A (ja) 2014-01-10 2019-12-12 エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
JP2021165604A Pending JP2022017283A (ja) 2014-01-10 2021-10-07 エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
JP2023196892A Pending JP2024028720A (ja) 2014-01-10 2023-11-20 エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用

Country Status (7)

Country Link
US (5) US9770443B2 (ja)
EP (1) EP3091976B1 (ja)
JP (4) JP7066321B2 (ja)
AU (4) AU2015204558B2 (ja)
CA (1) CA2936330C (ja)
NZ (2) NZ722927A (ja)
WO (1) WO2015106150A1 (ja)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10105356B2 (en) 2011-01-31 2018-10-23 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
WO2012106382A1 (en) 2011-01-31 2012-08-09 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
AU2014296032A1 (en) 2013-07-31 2016-03-17 Windward Pharma, Inc. Aerosol tyrosine kinase inhibitor compounds and uses thereof
NZ722927A (en) 2014-01-10 2022-07-29 Avalyn Pharma Inc Aerosol pirfenidone and pyridone analog compounds and uses thereof
MX2018002586A (es) 2015-09-01 2020-11-24 First Wave Bio Inc Composiciones para usarse en el tratamiento de afecciones asociadas a una repsuesta inflamatoria anómala.
CA3007097A1 (en) * 2015-12-01 2017-06-08 Cornell University Use of mitochondrial iron chelators for treatment of chronic obstructive pulmonary disease
EP3416628A1 (en) 2016-02-18 2018-12-26 Privo Technologies, Inc. Two-stage microparticle-based therapeutic delivery system and method
WO2017192767A1 (en) 2016-05-03 2017-11-09 Pneuma Respiratory, Inc. Droplet delivery device for delivery of fluids to the pulmonary system and methods of use
CN110461356A (zh) * 2016-12-29 2019-11-15 迈阿密大学 用于调节肺中炎性体活性和炎症的方法
US11840565B2 (en) 2016-12-29 2023-12-12 University Of Miami Methods and compositions for treating virus-associated inflammation
US20180235899A1 (en) 2017-02-17 2018-08-23 Privo Technologies, Inc. Particle-based multi-layer therapeutic delivery device and method
US10478403B1 (en) 2017-05-03 2019-11-19 Privo Technologies, Inc. Intraoperative topically-applied non-implantable rapid release patch
CA3064005C (en) 2017-05-19 2023-03-07 Pneuma Respiratory, Inc. Dry powder delivery device and methods of use
US20190054260A1 (en) * 2017-08-17 2019-02-21 Monzano Group LLC Nebulizer devices and methods
US11738158B2 (en) 2017-10-04 2023-08-29 Pneuma Respiratory, Inc. Electronic breath actuated in-line droplet delivery device and methods of use
EP4344719A3 (en) 2017-10-17 2024-06-05 Pneuma Respiratory, Inc. Nasal drug delivery apparatus and methods of use
US11771852B2 (en) 2017-11-08 2023-10-03 Pneuma Respiratory, Inc. Electronic breath actuated in-line droplet delivery device with small volume ampoule and methods of use
CN109758436A (zh) * 2017-11-09 2019-05-17 北京盈科瑞创新药物研究有限公司 一种雾化吸入用吡非尼酮冻干脂质体制剂及其制备方法
WO2019099836A1 (en) * 2017-11-16 2019-05-23 Northwestern University Inhaled formulation of a molecular inhibitor of wnt/beta-catenin signaling for treating interstitial lung diseases
US20230158257A1 (en) * 2018-01-08 2023-05-25 Pnuema Respiratory, Inc. Treatment of pulmonary cancers using an electronic breath actuated droplet delivery device
AU2019261329B2 (en) 2018-04-23 2024-09-05 Inspirmed Corp. Inhalable liposomal sustained release composition for use in treating pulmonary diseases
CN110742875B (zh) * 2018-07-05 2022-09-30 北京盈科瑞创新药物研究有限公司 一种吸入用吡非尼酮溶液制剂及其制备方法和应用
BR112021003071A2 (pt) 2018-08-22 2021-05-11 Avalyn Pharma Inc. composições especialmente formuladas de nintedanib e sais de nintedanib inalados
GB201815045D0 (en) * 2018-09-14 2018-10-31 Univ Ulster Bispecific antibody targeting IL-1R1 and NLPR3
TR201900204A2 (tr) * 2019-01-08 2019-02-21 Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi İnhalasyon yolu i̇le pi̇rfeni̇don uygulanmasi
AU2020274521A1 (en) 2019-05-16 2021-12-16 Aerovate Therapeutics, Inc. Imatinib formulations, manufacture, and uses thereof
US11464776B2 (en) 2019-05-16 2022-10-11 Aerovate Therapeutics, Inc. Inhalable imatinib formulations, manufacture, and uses thereof
WO2020261619A1 (ja) * 2019-06-26 2020-12-30 株式会社リコー 医薬組成物
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
CN115916162A (zh) * 2020-04-14 2023-04-04 埃克斯卡利伯制药股份有限公司 用于冠状病毒治疗的吡非尼酮
JP2024522529A (ja) * 2021-06-01 2024-06-21 プリボ テクノロジーズ,インコーポレイティド 二段階の微粒子に基づく改良型局所的治療剤送達システム
JP2024525200A (ja) 2021-06-22 2024-07-10 ニューマ・リスパイラトリー・インコーポレイテッド プッシュ排出を用いる液滴送達デバイス
CN114796122B (zh) * 2022-03-30 2023-03-24 山东大学 一种聚多巴胺载吡菲尼酮纳米粒及其制备方法和应用

Family Cites Families (181)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2587215A (en) 1949-04-27 1952-02-26 Frank P Priestly Inhalator
BE555319A (ja) 1956-03-21 1900-01-01
BE556587A (ja) 1957-01-31 1957-04-11
US3669113A (en) 1966-03-07 1972-06-13 Fisons Ltd Inhalation device
US3507277A (en) 1966-09-17 1970-04-21 Fisons Pharmaceuticals Ltd Inhalation device
US3456644A (en) 1967-01-19 1969-07-22 Dart Ind Inc Inhalation-actuated aerosol dispensing device
US3456645A (en) 1967-01-19 1969-07-22 Dart Ind Inc Inhalation-actuated aerosol dispensing device
US3456646A (en) 1967-01-19 1969-07-22 Dart Ind Inc Inhalation-actuated aerosol dispensing device
GB1268051A (en) 1968-06-07 1972-03-22 Fisons Pharmaceuticals Ltd Inhalation device
US3565070A (en) 1969-02-28 1971-02-23 Riker Laboratories Inc Inhalation actuable aerosol dispenser
US3636949A (en) 1969-08-08 1972-01-25 Armstrong Kropp Dev Corp Inhalation-initiated aerosol dispenser
BE758834A (fr) 1969-11-13 1971-05-12 Riker Laboratoires Inc Distributeur d'aerosol actionne par inhalation
GB1383761A (en) 1971-02-25 1974-02-12 Woodcraft Dc Inhalation device for use with an aerosol container
US3732864A (en) 1971-06-07 1973-05-15 Schering Corp Inhalation coordinated aerosol dispensing device
IT941426B (it) 1971-07-17 1973-03-01 Isf Spa Inalatore a camera di turbinio per sostanze medicamentose polveriformi
US3839346A (en) 1972-12-18 1974-10-01 Affiliated Med Res N-substituted pyridone and general method for preparing pyridones
CA1049411A (en) 1972-12-18 1979-02-27 Affiliated Medical Research N-substituted pyridone and general method for preparing pyridones
US4042699A (en) 1972-12-18 1977-08-16 Affiliated Medical Research, Inc. Method for reducing serum glucose levels
US4052509A (en) 1972-12-18 1977-10-04 Affiliated Medical Research, Inc. Method for reducing serum uric acid levels
FR2224175B1 (ja) 1973-04-04 1978-04-14 Isf Spa
IT1016489B (it) 1974-03-18 1977-05-30 Isf Spa Inalatore
US3971377A (en) 1974-06-10 1976-07-27 Alza Corporation Medicament dispensing process for inhalation therapy
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
ZA757570B (en) 1974-12-09 1977-07-27 Affiliated Med Res A useful n-substituted pyridone
US3948264A (en) 1975-05-21 1976-04-06 Mead Johnson & Company Inhalation device
US4147166A (en) 1977-05-02 1979-04-03 American Cyanamid Company Oral inhalator powder dispenser
BR8007911A (pt) 1979-12-06 1981-06-16 Glaxo Group Ltd Inalador aperfeicoado
SE438261B (sv) 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
US4688218A (en) 1981-07-15 1987-08-18 Etablissement Public De Diffusion Dit "Telediffusion De France" Multiplex channels for continuous flow for numerical signal
US4470412A (en) 1982-03-19 1984-09-11 Trutek Research, Inc. Inhalation valve
GB8328808D0 (en) 1983-10-28 1983-11-30 Riker Laboratories Inc Inhalation responsive dispensers
US4648393A (en) 1984-11-02 1987-03-10 Ackrad Laboratories, Inc. Breath activated medication spray
FR2575678B1 (fr) 1985-01-04 1988-06-03 Saint Gobain Vitrage Ejecteur pneumatique de poudre
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
PH26882A (en) 1985-07-30 1992-11-16 Glaxo Group Ltd Devices for administering medicaments to patients
US4809692A (en) 1986-01-31 1989-03-07 Trudell Medical Pediatric asthmatic medication inhaler
IT1204826B (it) 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
US4926852B1 (en) 1986-06-23 1995-05-23 Univ Johns Hopkins Medication delivery system phase one
US4790305A (en) 1986-06-23 1988-12-13 The Johns Hopkins University Medication delivery system
US5119806A (en) 1987-05-12 1992-06-09 Glaxo Inc. Inhalation device
KR910000142B1 (ko) 1987-05-29 1991-01-21 니혼 다바고 상교오 가부시기가이샤 담배용 필터
US4857311A (en) 1987-07-31 1989-08-15 Massachusetts Institute Of Technology Polyanhydrides with improved hydrolytic degradation properties
US4907538A (en) 1988-05-09 1990-03-13 Little Suamico Products Inc. Multiple bin cow feeder
US4832015A (en) 1988-05-19 1989-05-23 Trudell Medical Pediatric asthmatic inhaler
IT1217890B (it) 1988-06-22 1990-03-30 Chiesi Farma Spa Dispositivo per l'inalazione di aerosol dosati
FR2636716B1 (fr) 1988-09-21 1990-12-07 Staubli Sa Ets Dispositif pour l'accouplement des platines porte-elements des raccords multiples
DE68914932T2 (de) 1988-10-04 1994-08-11 Univ Johns Hopkins Inhalationsgerät für Aerosolen.
DK479189D0 (da) 1989-01-06 1989-09-28 Hans Gernot Schenk Inhalator
US5012804A (en) 1989-03-06 1991-05-07 Trudell Medical Medication inhaler with adult mask
US5012803A (en) 1989-03-06 1991-05-07 Trudell Medical Modular medication inhaler
GB8908647D0 (en) 1989-04-17 1989-06-01 Glaxo Group Ltd Device
DE69034007T2 (de) 1989-04-28 2003-05-08 Riker Laboratories Inc., Northridge Inhalationsvorrichtung für Trockenpulver
US4955371A (en) 1989-05-08 1990-09-11 Transtech Scientific, Inc. Disposable inhalation activated, aerosol device for pulmonary medicine
IT1237118B (it) 1989-10-27 1993-05-18 Miat Spa Inalatore multidose per farmaci in polvere.
US5716632A (en) 1989-11-22 1998-02-10 Margolin; Solomon B. Compositions and methods for reparation and prevention of fibrotic lesions
US5518729A (en) 1989-11-22 1996-05-21 Margolin; Solomon B. Compositions and methods for reparation and prevention of fibrotic lesions
US5310562A (en) 1989-11-22 1994-05-10 Margolin Solomon B Composition and method for reparation and prevention of fibrotic lesions
US5152456A (en) 1989-12-12 1992-10-06 Bespak, Plc Dispensing apparatus having a perforate outlet member and a vibrating device
US5113855A (en) 1990-02-14 1992-05-19 Newhouse Michael T Powder inhaler
US5192548A (en) 1990-04-30 1993-03-09 Riker Laboratoires, Inc. Device
GB9015077D0 (en) 1990-07-09 1990-08-29 Riker Laboratories Inc Inhaler
GB9015522D0 (en) 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
IT1243344B (it) 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
US5060643A (en) 1990-08-07 1991-10-29 Tenax Corporation Breath-activated inhalation device
GB9026025D0 (en) 1990-11-29 1991-01-16 Boehringer Ingelheim Kg Inhalation device
US5217004A (en) 1990-12-13 1993-06-08 Tenax Corporation Inhalation actuated dispensing apparatus
US5040527A (en) 1990-12-18 1991-08-20 Healthscan Products Inc. Metered dose inhalation unit with slide means
US5404871A (en) 1991-03-05 1995-04-11 Aradigm Delivery of aerosol medications for inspiration
AU651882B2 (en) 1991-05-14 1994-08-04 Visiomed Group Limited Aerosol inhalation device
ES2141108T3 (es) 1991-07-02 2000-03-16 Inhale Inc Metodo y dispositivo para proporcionar medicamentos en aerosol.
US5518179A (en) 1991-12-04 1996-05-21 The Technology Partnership Limited Fluid droplets production apparatus and method
DE4140689B4 (de) 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
DE4142238A1 (de) 1991-12-20 1993-06-24 Boehringer Ingelheim Kg Pulverinhalator mit pulvertraeger aus regelmaessigen mikrostrukturen
DE59307510D1 (de) 1992-05-29 1997-11-13 Ggu Gesundheits Umweltforsch Vorrichtung zur erzeugung inhalierbarer wirkstoffpartikel
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US5284133A (en) 1992-07-23 1994-02-08 Armstrong Pharmaceuticals, Inc. Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means
US5287847A (en) 1992-07-24 1994-02-22 Vortran Medical Technology, Inc. Universal nebulizer
NZ250105A (en) 1992-11-09 1996-07-26 Monaghan Canadian Ltd Inhalator mask; one-way valve opens upon exhalation
JP2924924B2 (ja) 1992-12-18 1999-07-26 シェリング・コーポレーション 粉末薬物のための吸入器
US5364838A (en) 1993-01-29 1994-11-15 Miris Medical Corporation Method of administration of insulin
ES2183839T3 (es) 1993-05-07 2003-04-01 Solomon B Margolin Composiciones y procedimiento de reparacion y de prevencion de lesiones del tipo de fibrosis.
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5642730A (en) 1994-06-17 1997-07-01 Trudell Medical Limited Catheter system for delivery of aerosolized medicine for use with pressurized propellant canister
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US6090822A (en) 1995-03-03 2000-07-18 Margolin; Solomon B. Treatment of cytokine growth factor caused disorders
US6114353A (en) 1995-03-03 2000-09-05 Margolin; Solomon B. Compositions and method for treatment of lymphomas, leukemias, and leiomyomas
US6427682B1 (en) 1995-04-05 2002-08-06 Aerogen, Inc. Methods and apparatus for aerosolizing a substance
US5921237A (en) 1995-04-24 1999-07-13 Dura Pharmaceuticals, Inc. Dry powder inhaler
US6672304B1 (en) 1995-06-08 2004-01-06 Innovative Devices, Llc Inhalation actuated device for use with metered dose inhalers (MDIs)
DK0837710T3 (da) 1995-06-21 2002-04-02 Sofotec Gmbh & Co Kg Lægemiddelpulverpatron med integreret doseringsindretning og inhalator for lægemidler på pulverform
AUPN417395A0 (en) 1995-07-14 1995-08-10 Techbase Pty. Ltd. An improved spacer
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
US6209538B1 (en) 1995-08-02 2001-04-03 Robert A. Casper Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
SE9502799D0 (sv) 1995-08-10 1995-08-10 Astra Ab Device in inhalers
US5962478A (en) 1995-09-19 1999-10-05 Margolin; Solomon B. Inhibition of tumor necrosis factor α
US5694920A (en) 1996-01-25 1997-12-09 Abrams; Andrew L. Inhalation device
US6026809A (en) 1996-01-25 2000-02-22 Microdose Technologies, Inc. Inhalation device
FR2747311B1 (fr) 1996-04-10 1998-08-14 Pf Medicament Inhalateur a poudre et a air comprime
JP2000513299A (ja) 1996-07-01 2000-10-10 アイティーティー・マニュファクチャリング・エンタープライジズ・インコーポレーテッド 液圧式ブレーキシステム
EP0944382A1 (en) 1996-09-30 1999-09-29 Brigham & Women's Hospital Methods and compounds for treatment of abnormal uterine bleeding
US6006747A (en) 1997-03-20 1999-12-28 Dura Pharmaceuticals, Inc. Dry powder inhaler
US6294350B1 (en) 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
US6293279B1 (en) 1997-09-26 2001-09-25 Trudell Medical International Aerosol medication delivery apparatus and system
US6003512A (en) 1997-11-13 1999-12-21 Lovelace Respiratory Research Institute Dust gun-aerosol generator and generation
DE1149602T1 (de) 1997-11-19 2002-04-04 Microflow Engineering S.A., Neuenburg/Neuchatel Sprühvorrichtung für einen für die Atemtherapie geeigneten Inhalator
US6223746B1 (en) 1998-02-12 2001-05-01 Iep Pharmaceutical Devices Inc. Metered dose inhaler pump
US6026807A (en) 1998-02-27 2000-02-22 Diemolding Corporation Metered dose inhaler cloud chamber
US6257233B1 (en) 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
DE59911149D1 (de) 1998-07-24 2004-12-30 Jago Res Ag Muttenz Medizinische aerosolformulierungen
AU1226099A (en) 1998-09-18 2000-04-10 Mepha Ag Topical formulation of alkyl-, phenyl-pyridone
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
NZ518401A (en) 1999-10-29 2004-01-30 Nektar Therapeutics Dry powder compositions having improved dispersivity
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
US6626173B2 (en) 2001-01-08 2003-09-30 Iep Pharmaceutical Devices Inc. Dry powder inhaler
DE10102846B4 (de) 2001-01-23 2012-04-12 Pari Pharma Gmbh Aerosolgenerator
ATE452637T1 (de) 2001-01-29 2010-01-15 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1- phenyl-2-(1h)-pyridon enthält
US6523536B2 (en) 2001-03-12 2003-02-25 Birdsong Medical Devices, Inc. Dual-canister inhaler having a spacer and easy to operate lever mechanism
US6759554B2 (en) 2001-04-24 2004-07-06 Massachusetts Institute Of Technology Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
JP4342940B2 (ja) 2001-08-06 2009-10-14 塩野義製薬株式会社 5−メチル−1−フェニル−2(1h)ピリジノンの製造方法
DE50106644D1 (de) 2001-10-18 2005-08-04 Pari Gmbh Inhalationstherapievorrichtung
EP1304130B1 (de) 2001-10-18 2004-06-23 PARI GmbH Spezialisten für effektive Inhalation Inhalationstherapievorrichtung
JP2005508220A (ja) 2001-10-24 2005-03-31 パーリ・ゲーエムベーハー 薬用組成物調製用具
AU2002347182A1 (en) 2001-12-18 2003-06-30 Mondobiotech Licensing Out Ag Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
US7550133B2 (en) 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
JP4542743B2 (ja) 2002-12-26 2010-09-15 Kdl株式会社 ピリドン誘導体の溶液状医薬組成物
EP1599171A2 (en) 2003-02-28 2005-11-30 Intermune, Inc. Combination therapy for treating alphavirus infection and liver fibrosis
US20070032457A1 (en) 2003-05-16 2007-02-08 Blatt Lawrence M Combination therapy for cancer treatment
WO2004103296A2 (en) 2003-05-16 2004-12-02 Intermune, Inc. Methods of treating idiopathic pulmonary fibrosis
US20070172446A1 (en) 2003-05-16 2007-07-26 Intermune, Inc. Synthetic chemokine receptor ligands and methods of use thereof
US20080025986A1 (en) 2003-06-06 2008-01-31 Ozes Osman N Methods of Treating Tnf-Mediated Disorders
US7491794B2 (en) 2003-10-14 2009-02-17 Intermune, Inc. Macrocyclic compounds as inhibitors of viral replication
WO2005040758A2 (en) 2003-10-24 2005-05-06 Intermune, Inc. Use of pirfenidone in therapeutic regimens
US7825133B2 (en) 2003-11-14 2010-11-02 Shanghai Genomics, Inc. Derivatives of pyridone and the use of them
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070053845A1 (en) 2004-03-02 2007-03-08 Shiladitya Sengupta Nanocell drug delivery system
US20070065359A1 (en) 2005-03-14 2007-03-22 Shiladitya Sengupta Nanocells for diagnosis and treatment of diseases and disorders
CN1846699A (zh) 2005-04-13 2006-10-18 中南大学湘雅医院 1-(取代苯基)-5-甲基-2-(1h) 吡啶酮(i)化合物用于制备抗除肾间质纤维化外其他器官纤维化或组织纤维化药物的应用
WO2006121518A2 (en) 2005-05-10 2006-11-16 Angiotech International Ag Electrical devices, anti-scarring agents, and therapeutic compositions
ES2524922T3 (es) 2005-05-10 2014-12-15 Intermune, Inc. Derivados de piridona para modular el sistema de proteína cinasa activada por estrés
US7838532B2 (en) 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
SG166791A1 (en) 2005-07-25 2010-12-29 Intermune Inc Novel macrocyclic inhibitors of hepatitis c virus replication
US20090192227A1 (en) 2005-08-24 2009-07-30 Rabindra Tirouvanziam N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
EP1931408A1 (en) 2005-09-06 2008-06-18 Intelligent Medical Technologies Pty Limited Nebuliser
NZ591443A (en) 2005-09-22 2013-04-26 Intermune Inc Granule formation of pirfenidone and pharmaceutically acceptable excipients
US20090170804A1 (en) 2005-10-31 2009-07-02 Roderick Phillips Pirfenidone/toll-like receptor (tlr) agonist compositions and methods for using them to stimulate production of granulocyte colonizing stimulating factor (g-csf)
WO2007053610A2 (en) 2005-11-01 2007-05-10 The Regents Of The University Of California Methods of treating atrial fibrillation wtih pirfenidone
EP2426134A3 (en) 2005-11-23 2012-07-04 Intermune, Inc. Method of modulating stress-activated protein kinase system
US20070203202A1 (en) 2005-12-02 2007-08-30 Robinson Cynthia Y Methods of reducing adverse events associated with pirfenidone therapy
RU2008152171A (ru) 2006-07-05 2010-08-10 Интермьюн, Инк. (Us) Новые ингибиторы вирусной репликации гепатита с
US7767700B2 (en) 2006-12-18 2010-08-03 Intermune, Inc. Method of providing pirfenidone therapy to a patient
WO2008083373A2 (en) 2006-12-31 2008-07-10 Sandisk Corporation Systems, methods, and integrated circuits with inrush-limited power islands
BRPI0811102A2 (pt) 2007-05-15 2014-09-23 Puretech Ventures Métodos e composições para tratar condições de pele
US20080287508A1 (en) 2007-05-18 2008-11-20 Intermune, Inc. Altering pharmacokinetics of pirfenidone therapy
US8178091B2 (en) 2007-05-21 2012-05-15 University Of Washington Compositions and methods for the treatment of respiratory disorders
MX2007006349A (es) 2007-05-29 2009-02-18 Cell Therapy And Technology S Nuevo proceso de sintesis para la obtencion de 5-metil-1-fenil-2-(ih)-piridona, composicion y uso de la misma.
CA2691379C (en) 2007-06-20 2015-06-09 Auspex Pharmaceuticals, Inc. Substituted n-aryl pyridinones
MX2007009796A (es) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
EP2237788A4 (en) 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF
US8012508B2 (en) 2008-01-15 2011-09-06 Abbott Cardiovascular Systems Inc. Method of targeting sustained release formulations of therapeutic agents to treat lung diseases
US8304413B2 (en) 2008-06-03 2012-11-06 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
BRPI0920026B1 (pt) 2008-10-07 2023-11-07 Horizon Orphan Llc Composição farmacêutica e respectivos usos
US7635707B1 (en) 2008-11-10 2009-12-22 Intermune, Inc. Pirfenidone treatment for patients with atypical liver function
US7566729B1 (en) 2008-11-10 2009-07-28 Intermune, Inc. Modifying pirfenidone treatment for patients with atypical liver function
AU2009344851A1 (en) 2008-12-19 2011-06-23 The Regents Of The University Of California Use of epidermal growth factor inhibitors in the treatment of viral infection
EP2389227A4 (en) 2009-01-26 2012-08-08 Intermune Inc METHODS OF TREATING ACUTE MYOCARDIAL INFARCTION AND RELATED DISORDERS
AU2010248758A1 (en) 2009-05-15 2011-11-24 Intermune, Inc. Methods of treating HIV patients with anti-fibrotics
WO2010135470A1 (en) 2009-05-19 2010-11-25 Intermune, Inc. Pifenidone derivatives for treating bronchial asthma
TWI434833B (zh) 2009-06-03 2014-04-21 Intermune Inc 用於合成吡非尼酮(pirfenidone)的改良方法
CN102639505A (zh) 2009-10-02 2012-08-15 阿斯利康(瑞典)有限公司 用作嗜中性白细胞弹性蛋白酶抑制剂的吡啶-2-酮化合物
US8084475B2 (en) 2009-12-04 2011-12-27 Intermune, Inc. Pirfenidone therapy and inducers of cytochrome P450
US7816383B1 (en) 2009-12-04 2010-10-19 Intermune, Inc. Methods of administering pirfenidone therapy
WO2012106382A1 (en) 2011-01-31 2012-08-09 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US10105356B2 (en) * 2011-01-31 2018-10-23 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
MY168300A (en) 2011-09-14 2018-10-25 Shionogi & Co Pharmaceutical Composition for Inhalation
HUE063581T2 (hu) 2012-07-24 2024-01-28 Avalyn Pharma Inc Aeroszol pirfenidon és piridon analóg vegyületek
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US20140094456A1 (en) 2012-10-02 2014-04-03 Intermune, Inc. Anti-fibrotic pyridinones
NZ722927A (en) 2014-01-10 2022-07-29 Avalyn Pharma Inc Aerosol pirfenidone and pyridone analog compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP2017502064A5 (ja)
JP2019031514A5 (ja)
JP2018199688A5 (ja)
JP2014503598A5 (ja)
JP2015523395A5 (ja)
JP2016527275A5 (ja)
JP2020073494A5 (ja)
ES2792682T3 (es) Métodos para el tratamiento de enfermedades pulmonares con estabilizadores de mastocitos
JP6712231B2 (ja) ニコチン粉末吸入器
JP2008536546A5 (ja)
NZ760541A (en) Aerosol pirfenidone and pyridone analog compounds and uses thereof
RU2013103534A (ru) Лечение легочных инфекций с помощью введения тобрамицина путем аэролизации
US8479728B2 (en) Effective delivery of nanoparticles and micrometer-sized pharmaceutical aerosols to the lung through enhanced condensational growth
JP2017513648A5 (ja)
WO2009027095A4 (en) Aerosols for sinunasal drug delivery
JP2011520911A5 (ja)
WO2005084638A3 (en) Formulations decreasing infectivity of pulmonary diseases
JP2016515576A5 (ja)
JP2019534270A5 (ja)
JP2016534142A5 (ja)
JP2020527377A5 (ja)
JP6066350B2 (ja) エアロゾルボーラスとしてのイロプロストの投与
HRP20221185T1 (hr) Beta-ukosnica peptidomimetik s inhibitorskom aktivnošću elastase i njegovi oblici doziranja aerosolom
JP2009528337A (ja) ネブライザー処方物
ES2441733T3 (es) Formulación del nebulizador